Edmond Chen

5.0k total citations
22 papers, 603 citations indexed

About

Edmond Chen is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Edmond Chen has authored 22 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 5 papers in Internal Medicine. Recurrent topics in Edmond Chen's work include Antiplatelet Therapy and Cardiovascular Diseases (15 papers), Acute Myocardial Infarction Research (12 papers) and Atrial Fibrillation Management and Outcomes (8 papers). Edmond Chen is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (15 papers), Acute Myocardial Infarction Research (12 papers) and Atrial Fibrillation Management and Outcomes (8 papers). Edmond Chen collaborates with scholars based in United States, Canada and Australia. Edmond Chen's co-authors include G. Michael Vincent, Osmar Antonio Centurión, Peter M. Kistler, Laura Rodríguez Chávez, Xiaohong Chen, Philippe Maury, Jonathan M. Kalman, Andrew J Sands, Li Zhang and Franz Xaver Roithinger and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Edmond Chen

22 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edmond Chen United States 11 512 151 92 92 67 22 603
Christian Pfluecke Germany 13 366 0.7× 152 1.0× 46 0.5× 49 0.5× 53 0.8× 44 563
Cem Nazlı Türkiye 12 282 0.6× 189 1.3× 26 0.3× 34 0.4× 150 2.2× 61 474
Chu‐Pak Lau Hong Kong 14 694 1.4× 109 0.7× 72 0.8× 31 0.3× 14 0.2× 25 814
Rui Plácido Portugal 11 255 0.5× 90 0.6× 48 0.5× 37 0.4× 133 2.0× 49 393
Elias B. Hanna United States 12 344 0.7× 200 1.3× 19 0.2× 45 0.5× 90 1.3× 48 487
Eduardo J. de Marchena United States 10 158 0.3× 88 0.6× 36 0.4× 19 0.2× 62 0.9× 21 274
Peter Baker United States 11 132 0.3× 102 0.7× 43 0.5× 153 1.7× 88 1.3× 39 476
Jan Res Netherlands 10 823 1.6× 349 2.3× 56 0.6× 37 0.4× 70 1.0× 13 959
Zafer Işılak Türkiye 10 234 0.5× 96 0.6× 29 0.3× 25 0.3× 61 0.9× 69 350
Théo Pezel France 15 595 1.2× 119 0.8× 36 0.4× 11 0.1× 47 0.7× 118 835

Countries citing papers authored by Edmond Chen

Since Specialization
Citations

This map shows the geographic impact of Edmond Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edmond Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edmond Chen more than expected).

Fields of papers citing papers by Edmond Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edmond Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edmond Chen. The network helps show where Edmond Chen may publish in the future.

Co-authorship network of co-authors of Edmond Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Edmond Chen. A scholar is included among the top collaborators of Edmond Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edmond Chen. Edmond Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Capell, Warren H., Marc P. Bonaca, Mark R. Nehler, et al.. (2018). Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD). American Heart Journal. 199. 83–91. 84 indexed citations
3.
4.
Cornel, Jan H., Pierluigi Tricoci, Yuliya Lokhnygina, et al.. (2015). Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non–ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial). The American Journal of Cardiology. 115(10). 1325–1332. 15 indexed citations
5.
Déry, Jean‐Pierre, Kenneth W. Mahaffey, Pierluigi Tricoci, et al.. (2015). Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar. Catheterization and Cardiovascular Interventions. 88(2). 163–173. 6 indexed citations
6.
Valgimigli, Marco, Pierluigi Tricoci, Zhen Huang, et al.. (2014). Usefulness and Safety of Vorapaxar in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (from the TRACER Trial). The American Journal of Cardiology. 114(5). 665–673. 17 indexed citations
7.
Tricoci, Pierluigi, Yuliya Lokhnygina, Zhen Huang, et al.. (2014). Vorapaxar with or without clopidogrel after non–ST-segment elevation acute coronary syndromes: Results from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome trial. American Heart Journal. 168(6). 869–877.e1. 16 indexed citations
8.
Jones, W. Schuyler, Pierluigi Tricoci, Zhen Huang, et al.. (2014). Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: Insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER). American Heart Journal. 168(4). 588–596. 43 indexed citations
9.
Storey, Robert F., Susan S. Smyth, David J. Moliterno, et al.. (2014). Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. Thrombosis and Haemostasis. 112(5). 883–891. 22 indexed citations
10.
Jones, Schuyler, Pierluigi Tricoci, Zhen Huang, et al.. (2013). Abstract 17939: Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients With Peripheral Artery Disease: Results From TRACER. Circulation. 1 indexed citations
11.
Jones, Schuyler, Pierluigi Tricoci, Zhen Huang, et al.. (2013). Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients With Peripheral Artery Disease : Results From TRACER. Circulation. 128(22). 1 indexed citations
12.
Armaganijan, Luciana, Renato D. Lópes, Zhen Huang, et al.. (2013). Efficacy and Safety of Vorapaxar in Elderly Patients With Non-ST-Segment Elevation Acute Coronary Syndrome : Insights From the TRACER Trial. Circulation. 128(22). 1 indexed citations
13.
Mahaffey, Kenneth W., Zhen Huang, Lars Wallentin, et al.. (2013). Association of Aspirin Dose and Vorapaxar Safety and Efficacy in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome (from the TRACER Trial). The American Journal of Cardiology. 113(6). 936–944. 16 indexed citations
14.
Tricoci, Pierluigi, Edmond Chen, Megan L. Neely, et al.. (2013). CYP2C19 Polymorphism and PON-1 Activity in NSTE ACS : Vorapaxar Effect in Relation to Clopidogrel Metabolism in the TRACER Trial. Circulation. 128(22). 2 indexed citations
15.
Cornel, Jan H., Pierluigi Tricoci, J.R. Horton, et al.. (2013). EFFECTS OF GLYCOPROTEIN IIB/IIIA INHIBITORS IN COMBINATION WITH VORAPAXAR, A PLATELET THROMBIN-RECEPTOR ANTAGONIST, AMONG PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES: INSIGHTS FROM THE TRACER TRIAL. Journal of the American College of Cardiology. 61(10). E102–E102. 3 indexed citations
16.
17.
18.
Viskin, Sami, Andrew J Sands, Edmond Chen, et al.. (2005). Inaccurate electrocardiographic interpretation of long QT: The majority of physicians cannot recognize a long QT when they see one. Heart Rhythm. 2(6). 569–574. 274 indexed citations
19.
Grzybowski, Mary, Robert D. Welch, Lori Parsons, et al.. (2004). The Association between White Blood Cell Count and Acute Myocardial Infarction In-hospital Mortality: Findings from the National Registry of Myocardial Infarction. Academic Emergency Medicine. 11(10). 1049–1060. 17 indexed citations
20.
Grzybowski, Mary, Robert D. Welch, Lori Parsons, et al.. (2004). The Association between White Blood Cell Count and Acute Myocardial Infarction In‐hospital Mortality: Findings from the National Registry of Myocardial Infarction. Academic Emergency Medicine. 11(10). 1049–1060. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Pfluecke Breakdown of academic impact, for papers by Cem Nazlı Breakdown of academic impact, for papers by Chu‐Pak Lau Breakdown of academic impact, for papers by Rui Plácido Breakdown of academic impact, for papers by Elias B. Hanna Breakdown of academic impact, for papers by Eduardo J. de Marchena Breakdown of academic impact, for papers by Peter Baker Breakdown of academic impact, for papers by Jan Res Breakdown of academic impact, for papers by Zafer Işılak Breakdown of academic impact, for papers by Théo Pezel
Rankless by CCL
2026